» Articles » PMID: 35994032

From Bugs to Bedside: Functional Annotation of Human Genetic Variation for Neurological Disorders Using Invertebrate Models

Overview
Journal Hum Mol Genet
Date 2022 Aug 22
PMID 35994032
Authors
Affiliations
Soon will be listed here.
Abstract

The exponential accumulation of DNA sequencing data has opened new avenues for discovering the causative roles of single-nucleotide polymorphisms (SNPs) in neurological diseases. The opportunities emerging from this are staggering, yet only as good as our abilities to glean insights from this surplus of information. Whereas computational biology continues to improve with respect to predictions and molecular modeling, the differences between in silico and in vivo analysis remain substantial. Invertebrate in vivo model systems represent technically advanced, experimentally mature, high-throughput, efficient and cost-effective resources for investigating a disease. With a decades-long track record of enabling investigators to discern function from DNA, fly (Drosophila) and worm (Caenorhabditis elegans) models have never been better poised to serve as living engines of discovery. Both of these animals have already proven useful in the classification of genetic variants as either pathogenic or benign across a range of neurodevelopmental and neurodegenerative disorders-including autism spectrum disorders, ciliopathies, amyotrophic lateral sclerosis, Alzheimer's and Parkinson's disease. Pathogenic SNPs typically display distinctive phenotypes in functional assays when compared with null alleles and frequently lead to protein products with gain-of-function or partial loss-of-function properties that contribute to neurological disease pathogenesis. The utility of invertebrates is logically limited by overt differences in anatomical and physiological characteristics, and also the evolutionary distance in genome structure. Nevertheless, functional annotation of disease-SNPs using invertebrate models can expedite the process of assigning cellular and organismal consequences to mutations, ascertain insights into mechanisms of action, and accelerate therapeutic target discovery and drug development for neurological conditions.

Citing Articles

Utilizing Spermatogenesis and Fertilization Mutants as a Model for Human Disease.

Perez S, Augustineli H, Marcello M J Dev Biol. 2025; 13(1).

PMID: 39982357 PMC: 11843878. DOI: 10.3390/jdb13010004.


Dietary Curcumin Intake and Its Effects on the Transcriptome and Metabolome of .

Belcher S, Flores-Iga G, Natarajan P, Crummett G, Talavera-Caro A, Gracia-Rodriguez C Int J Mol Sci. 2024; 25(12).

PMID: 38928266 PMC: 11203963. DOI: 10.3390/ijms25126559.


Back to the future through the wormhole: Caenorhabditis elegans as a preclinical model.

Caldwell G Dis Model Mech. 2023; 16(6).

PMID: 37309665 PMC: 10281264. DOI: 10.1242/dmm.050333.


Mechanistic impacts of bacterial diet on dopaminergic neurodegeneration in a α-synuclein model of Parkinson's disease.

Gaeta A, Willicott K, Willicott C, McKay L, Keogh C, Altman T iScience. 2023; 26(6):106859.

PMID: 37260751 PMC: 10227375. DOI: 10.1016/j.isci.2023.106859.


Attenuation of Dopaminergic Neurodegeneration in a Parkinson's Model through Regulation of Xanthine Dehydrogenase (XDH-1) Expression by the RNA Editase, ADR-2.

Starr L, McKay L, Peter K, Seyfarth L, Berkowitz L, Caldwell K J Dev Biol. 2023; 11(2).

PMID: 37218814 PMC: 10204437. DOI: 10.3390/jdb11020020.


References
1.
Ernst C, Hahnen E, Engel C, Nothnagel M, Weber J, Schmutzler R . Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics. BMC Med Genomics. 2018; 11(1):35. PMC: 5870501. DOI: 10.1186/s12920-018-0353-y. View

2.
Grenn F, Kim J, Makarious M, Iwaki H, Illarionova A, Brolin K . The Parkinson's Disease Genome-Wide Association Study Locus Browser. Mov Disord. 2020; 35(11):2056-2067. PMC: 7754106. DOI: 10.1002/mds.28197. View

3.
Monfrini E, Zech M, Steel D, Kurian M, Winkelmann J, Di Fonzo A . HOPS-associated neurological disorders (HOPSANDs): linking endolysosomal dysfunction to the pathogenesis of dystonia. Brain. 2021; 144(9):2610-2615. DOI: 10.1093/brain/awab161. View

4.
Iossifov I, ORoak B, Sanders S, Ronemus M, Krumm N, Levy D . The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014; 515(7526):216-21. PMC: 4313871. DOI: 10.1038/nature13908. View

5.
Polychronopoulos D, King J, Nash A, Tan G, Lenhard B . Conserved non-coding elements: developmental gene regulation meets genome organization. Nucleic Acids Res. 2017; 45(22):12611-12624. PMC: 5728398. DOI: 10.1093/nar/gkx1074. View